NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000001933

Registered date:02/05/2009

Migration of alpha-GalactosylCeramide-pulsed dendritic cells after submucosal or subcutaneous administration in patients.

Basic Information

Recruitment status
Health condition(s) or Problem(s) studiedHead and neck squamous cell carcinoma
Date of first enrollment2008/08/01
Target sample size15
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Sub-mucosal or subcutaneous administrations of 111In-labeled alpha-GalactosylCeramide pulsed DCs are performed on day 7 after the entry.

Outcome(s)

Primary OutcomeThe migration of the radioactive 111In-labeled DCs.
Secondary OutcomeThe immunological responses.

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum80years-old
GenderMale and Female
Include criteria
Exclude criteriaInfection; a history of hepatitis; a positive response for hepatitis B surface antigen, or human immunodeficiency virus (HIV), hepatitis C virus, or human T-lymphotrophic virus antibodies; serious cardiac disease; recieived concurrent corticosteroid therapy; pregnancy or lactation; autoimmune diseases; been judged to be inappropriate to participate in this study by principle investigator or co-investigator.

Related Information

Contact

public contact
Name Shigetoshi Horiguchi
Address 1-8-1 Inohana, Chuo-ku, Chiba, Japan Japan
Telephone 043-222-7171
E-mail
Affiliation Graduate School of Medicine, Chiba University Department of Otorhinolaryngology, Head and Neck Surgery
scientific contact
Name Yoshitaka Okamoto
Address 1-8-1 Inohana, Chuo-ku, Chiba, Japan Japan
Telephone
E-mail
Affiliation Graduate School of Medicine, Chiba University Department of Otorhinolaryngology, Head and Neck Surgery